We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+1.12%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$704M
AUM Growth
+$17.6M
(+2.6%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
2.5%
Top 10 Holdings %
Top 10 Hldgs %
34.59%
Holding
228
New
17
Increased
78
Reduced
95
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
J.M. Smucker
SJM
|
+$2.94M |
| 2 |
PayPal
PYPL
|
+$2.45M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$2.38M |
| 4 |
Analog Devices
ADI
|
+$1.8M |
| 5 |
Adient
ADNT
|
+$1.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$1.63M |
| 2 |
IPG Photonics
IPGP
|
+$1.49M |
| 3 |
Perrigo
PRGO
|
+$1.24M |
| 4 |
Kroger
KR
|
+$1.05M |
| 5 |
Gilead Sciences
GILD
|
+$990K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.52% |
| 2 | Technology | 19.56% |
| 3 | Industrials | 16.26% |
| 4 | Consumer Staples | 11.7% |
| 5 | Financials | 8.33% |
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
HA
NIM
Reynders McVeigh Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Reynders McVeigh Capital Management held 228 positions worth $704M, up 2.6% from $686M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Reynders McVeigh Capital Management's Q4 2016 filing shows 17 new, 78 increased, 95 reduced and 3 closed positions. Its largest new stake was Adient: 31,202 shares worth $1.83M. The largest sale was Teva Pharmaceuticals, an estimated $1.63M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q4 2016 buy was Adient: 31,202 shares worth $1.83M.
- Reynders McVeigh Capital Management added most to J.M. Smucker in Q4 2016, an estimated $2.94M increase.
- Reynders McVeigh Capital Management's biggest Q4 2016 reduction was Teva Pharmaceuticals, cutting an estimated $1.63M.
- Reynders McVeigh Capital Management fully exited Blackrock in Q4 2016, selling an estimated $275K.
- Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $704M portfolio in Q4 2016.
- Reynders McVeigh Capital Management opened 17 new positions and closed 3 in Q4 2016.
- Reynders McVeigh Capital Management's portfolio value rose 2.6% quarter-over-quarter to $704M.
Based on Reynders McVeigh Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.